StonvexLoading…
StonvexStonvexStonvexCore line items from SRE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $12.42B | $11.82B | $14.85B | $13.72B |
Operating Income | $1.79B | $2.71B | $3.26B | $2.01B |
Net Income | $1.84B | $2.86B | $3.08B | $2.14B |
EPS (Diluted) | $2.75 | $4.42 | $4.79 | $3.31 |
Total Assets | $110.88B | $96.16B | $87.18B | $78.57B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $29.00M | $1.56B | $236.00M | $370.00M |
Free Cash Flow OCF − CapEx | $-6.05B | $-3.31B | $-2.18B | $-4.21B |
Shares Outstanding | 652.73M | 650.63M | 631.43M | 628.67M |